A collaborative initiative to describe the neurological features of COVID-19
What are the neurological and neuropsychiatric effects of COVID-19?
What is this study about?
CoroNerve is a collaborative initiative to describe the neurological features of COVID-19. There is an urgent need for prospective, nationwide, high-quality data collection to inform management and research into the neurological sequelae. In the UK, we have partnered with a growing list of Professional Societies including BASP, ABN, BPNA, RCPsych.
The CoroNerve Studies Group is a collaborative effort to study the neurological and neuropsychiatric effects of COVID-19, and was established through a partnership of the University of Southampton, University of Newcastle, Liverpool University and UCL, with the relevant UK Professional Societies.
Type of study
Who is funding the study?
Contributions from the Universities of Southampton, Newcastle and Liverpool, and an Academic grant awarded from Gilead Sciences in January 2021.
When is it taking place?
March 2020 onwards
Where is it taking place?
This is a UK wide collaborative effort and all the key neurological, intensive care, and psychiatric professional societies are involved.
Who is included?
Neuropsychiatric cases (adult and paediatric) as reported by members of the collaborating societies. Detailed case reports are submitted through the database hosted by the University of Southampton